AU665690B2 - Indole derivative - Google Patents

Indole derivative Download PDF

Info

Publication number
AU665690B2
AU665690B2 AU42711/93A AU4271193A AU665690B2 AU 665690 B2 AU665690 B2 AU 665690B2 AU 42711/93 A AU42711/93 A AU 42711/93A AU 4271193 A AU4271193 A AU 4271193A AU 665690 B2 AU665690 B2 AU 665690B2
Authority
AU
Australia
Prior art keywords
group
lower alkyl
phenyl
alkyl group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42711/93A
Other languages
English (en)
Other versions
AU4271193A (en
Inventor
Masatoshi Inai
Jun Kanaya
Masako Moritake
Tadanao Shibutani
Akie Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU4271193A publication Critical patent/AU4271193A/en
Application granted granted Critical
Publication of AU665690B2 publication Critical patent/AU665690B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU42711/93A 1992-05-08 1993-04-28 Indole derivative Ceased AU665690B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11612692 1992-05-08
JP4-116126 1992-05-08
PCT/JP1993/000560 WO1993023374A1 (fr) 1992-05-08 1993-04-28 Derive d'indole

Publications (2)

Publication Number Publication Date
AU4271193A AU4271193A (en) 1993-12-13
AU665690B2 true AU665690B2 (en) 1996-01-11

Family

ID=14679354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42711/93A Ceased AU665690B2 (en) 1992-05-08 1993-04-28 Indole derivative

Country Status (7)

Country Link
US (1) US5496844A (enExample)
EP (1) EP0639567A1 (enExample)
KR (1) KR950701317A (enExample)
AU (1) AU665690B2 (enExample)
CA (1) CA2135160A1 (enExample)
TW (1) TW239125B (enExample)
WO (1) WO1993023374A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69504637T2 (de) * 1994-02-22 1999-05-06 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Indolderivate zur behandlung von östrogenabhängigen neoplasmen und krankheiten
AU717422B2 (en) * 1995-09-01 2000-03-23 Eli Lilly And Company Indolyl neuropeptide Y receptor antagonists
GB9523999D0 (en) 1995-11-23 1996-01-24 Lilly Co Eli Indolyl neuropeptide y receptor antagonists
US5985910A (en) * 1996-04-19 1999-11-16 American Home Products Corporation 3- [4- (2- Phenyl-Indole-1-ylmethyl) Phenyl]- Acrylamides as estrogenic agents
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
DK0802183T3 (da) * 1996-04-19 2002-02-04 American Home Prod Østrogenforbindelser
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US5780497A (en) * 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
FR2751966B1 (fr) * 1996-08-01 1998-10-30 Union Pharma Scient Appl Nouveaux derives 1,2-diarylindoles, leurs procedes de preparation, et leurs utilisations en therapeutique
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
US6326392B1 (en) 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
CN1173973C (zh) * 1998-05-12 2004-11-03 惠氏公司 苯并咔唑和茚并吲哚衍生的雌激素药
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
WO1999059969A1 (en) * 1998-05-15 1999-11-25 American Home Products Corporation Compositions comprising 2-phenyl-indole compounds and estrogen formulations
EP1076558B1 (en) * 1998-05-15 2003-07-16 Wyeth 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
JP4637365B2 (ja) 1999-02-26 2011-02-23 エミスフェアー・テクノロジーズ・インク 活性剤デリバリーのための化合物及び組成物
MXPA01008911A (es) * 1999-03-04 2002-10-23 Wyeth Corp Benzoil-indoles n-sustituidos utiles como agentes estrogenicos..
US6380185B1 (en) 1999-03-04 2002-04-30 American Home Products Corporation N-substituted benzoyl indoles as estrogenic agents
JP4832647B2 (ja) 1999-03-26 2011-12-07 ユーロ−セルティック エス． ア． アリール置換ピラゾール、イミダゾール、オキサゾール、チアゾールおよびピロール、ならびにそれらの使用
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
BR0013943A (pt) * 1999-09-13 2002-05-14 American Home Prod Conjugados de glicopiranosìdeos de 2-(4-hidróxi-fenil)-1-[4-(2-amin-1-il-etóxi)-benzil]-1h-indo l-5-óis
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
WO2003007955A2 (en) * 2001-07-20 2003-01-30 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
MXPA05000898A (es) 2002-07-22 2005-05-16 Lilly Co Eli Moduladores de receptor de estrogeno selectivos que contiene, un grupo fenilsulfonilo.
GB0224557D0 (en) * 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1689389A4 (en) * 2003-12-04 2009-06-17 Nat Health Research Institutes INDOLE COMPOUNDS
CA2558051C (en) * 2004-03-16 2013-03-12 Boehringer Ingelheim International Gmbh Palladium catalyzed indolization of 2-bromo or chloroanilines
DOP2006000016A (es) * 2005-01-26 2006-07-31 Aventis Pharma Inc 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
EP2211848A1 (en) 2007-10-16 2010-08-04 Repros Therapeutics Inc. Trans-clomiphene for metabolic syndrome
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
ES2681023T3 (es) 2012-02-29 2018-09-11 Repros Therapeutics Inc. Terapia de combinación para tratar el déficit de andrógenos
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CN108348605B (zh) 2015-11-10 2023-06-09 帕拉卡林治疗公司 用pdgf-cc抑制剂和抗雌激素治疗er阴性乳癌

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
US4543360A (en) * 1981-09-10 1985-09-24 Degussa Aktiengesellschaft 2-(Hydroxy-phenyl)-indoles and process for their production
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
WO1993023374A1 (fr) 1993-11-25
KR950701317A (ko) 1995-03-23
US5496844A (en) 1996-03-05
EP0639567A1 (en) 1995-02-22
TW239125B (enExample) 1995-01-21
AU4271193A (en) 1993-12-13
CA2135160A1 (en) 1993-11-25
EP0639567A4 (en) 1994-12-27

Similar Documents

Publication Publication Date Title
AU665690B2 (en) Indole derivative
CA2178161C (en) Indole derivatives
US4929635A (en) New derivatives of 4-vinyl benzoic acid, process for their preparation and their uses in therapeutics and as ligands
HU228594B1 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
UA79283C2 (en) Pyrrolidinium derivatives, process for the preparation thereof (variants), intermediate (variants), pharmaceutical composition, combined product
CA2285264A1 (en) Condensed pyridazine derivatives, their production and use
AU593039B2 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
WO2022001971A1 (zh) 并环吲唑类化合物
JPH0324080A (ja) Ｎ‐ヘテロアリール‐プリン‐６‐アミンおよびその製法
BE897828A (nl) Piperazinederivaten met anti-cholinergische en/of anti-histamineactiviteit.
WO1993013075A1 (en) 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents
US8394824B2 (en) Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine
KR840001775B1 (ko) 헤테로 사이클릭 유도체의 제조방법
JPS59176265A (ja) ピペラジニルアルカン化合物
US4048322A (en) Bronchially effective xanthene-9-carboxylates
CA1320200C (en) Cyclic ether derivatives having an anti-shock activity or a paf-antagonistic activity
CN113999211A (zh) 一类特异性抗前列腺癌活性的含1,2,3-三氮唑的吲唑骨架衍生物
US5741800A (en) Azolyl-cyclic amine derivates with immunomodulatory activity
PT99280B (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
JP7264829B2 (ja) セレタリシブの結晶形態
JP2013535480A (ja) ２−［２−［［（４−メトキシ−２，６−ジメチルフェニル）スルホニル］−（メチル）アミノ］エトキシ］−ｎ−メチル−ｎ−［３−（４−メチルピペラジン−１−イル）シクロヘキシル］アセトアミドの酸付加塩及びそのブラジキニンｂ１受容体アンタゴニストとしての使用
EP0750607A1 (en) 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
EP0623114A1 (en) Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists
CZ280202B6 (cs) Nové deriváty kyseliny thiofen-2-karboxylové a způsob jejich výroby
EP2435414A1 (en) Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use